{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:56:24Z","timestamp":1763754984346,"version":"3.45.0"},"reference-count":37,"publisher":"Oncology Nursing Society (ONS)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJON"],"published-print":{"date-parts":[[2020,8,1]]},"DOI":"10.1188\/20.cjon.439-443","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T09:49:26Z","timestamp":1594979366000},"page":"439-443","source":"Crossref","is-referenced-by-count":4,"title":["African American Patients With Multiple Myeloma: Optimizing Care to Decrease Racial Disparities"],"prefix":"10.1188","volume":"24","author":[{"given":"Amy","family":"Pierre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Ailawadhi, S., Advani, P., Yang, D., Ghosh, R., Swaika, A., Roy, V., . . . Chanan-Khan, A. (2015). Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis. Cancer,\u00a0122(4), 618\u2013625. https:\/\/doi.org\/10.1002\/cncr.29771","DOI":"10.1002\/cncr.29771"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Ailawadhi, S., Frank, R.D., Advani, P., Swaika, A., Temkit, M., Menghani, R., . . . Chanan-Khan, A.A. (2017). Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: A SEER-Medicare analysis.\u00a0Cancer Medicine,\u00a06(12), 2876\u20132885.","DOI":"10.1002\/cam4.1246"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Ailawadhi, S., Jacobus, S., Sexton, R., Stewart, A.K., Dispenzieri, A., Hussein, M.A., . . . Rajkumar, S.V. (2018). Disease and outcome disparities in multiple myeloma: Exploring the role of race\/ethnicity in the cooperative group clinical trials.\u00a0Blood Cancer Journal,\u00a08(7), 67. https:\/\/doi.org\/10.1038\/s41408-018-0102-7","DOI":"10.1038\/s41408-018-0102-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Ailawadhi, S., Parikh, K., Abouzaid, S., Zhou, Z., Tang, W., Clancy, Z., . . . Xie, J. (2019). Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: A SEER-Medicare analysis.\u00a0Blood Advances,\u00a03(20), 2986\u20132994. https:\/\/doi.org.10.1182\/bloodadvances.2019000308","DOI":"10.1182\/bloodadvances.2019000308"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Augustin, A., Ralston, P.A., Young-Clark, I., & Coccia, C.C. (2019). The Breast-Cancer Education and Wellness (BE Well) intervention: Congregants\u2019 intended participation, actual participation, and perceived health outcomes.\u00a0Health Education and Behavior,\u00a046(5), 843\u2013852. https:\/\/doi.org\/10.1177\/1090198119841114","DOI":"10.1177\/1090198119841114"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Baker, A., Braggio, E., Jacobus, S., Jung, S., Larson, D., Therneau, T., . . . Fonseca, R. (2013). Uncovering the biology of multiple myeloma among African Americans: A comprehensive genomics approach.\u00a0Blood,\u00a0121(16), 3147\u20133152. https:\/\/doi.org\/10.1182\/blood-2012-07-443606","DOI":"10.1182\/blood-2012-07-443606"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Banavali, A., Neculiseanu, E., Draksharam, P.L., Datla, S., Savjani, M., Park, J., . . . Taiwo, E.O. (2018). Findings of multiple myeloma in Afro-Caribbean patients in the United States.\u00a0Journal of Global Oncology, 4, 1\u20136. https:\/\/doi.org\/10.1200\/jgo.17.00133","DOI":"10.1200\/JGO.17.00133"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Banda, B.R., Libin, A.V., Wang, H., & Swain, S.M. (2012). A pilot study of a culturally targeted video intervention to increase participation of African American patients in cancer clinical trials.\u00a0Oncologist, 17(5), 708\u2013714. https:\/\/doi.org\/10.1634\/theoncologist.2011-0454","DOI":"10.1634\/theoncologist.2011-0454"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Baughn, L.B., Pearce, K., Larson, D., Polley, M.Y., Elhaik, E., Baird, M., . . . Rajkumar, S.V. (2018). Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry.\u00a0Blood Cancer Journal,\u00a08(10), 96.","DOI":"10.1038\/s41408-018-0132-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Blakeney, N., Michaels, M., Green, M., Richmond, A., Long, D., Robinson, W.S., . . . Corbie-Smith, G. (2014). Collaborative development of clinical trials education programs for African-American community-based organizations.\u00a0Journal of Cancer Education,\u00a030(2), 400\u2013406.","DOI":"10.1007\/s13187-014-0673-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Blue, B.J., Luo, S., Sanfilippo, K.M., Ganti, A., Gumbel, J., O\u2019Brian, K., & Carson, K.R. (2017). Race-based differences in routine cytogenetic profiles of patients with multiple myeloma. British Journal of Haematology,\u00a0176(2), 322\u2013324. https:\/\/doi.org\/10.1111\/bjh.13950","DOI":"10.1111\/bjh.13950"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Brown, O., ten Ham-Baloyi, W., van Rooyen, D.R., Aldous, C., & Marais, L.C. (2016). Culturally competent patient-provider communication in the management of cancer: An integrative literature review.\u00a0Global Health Action,\u00a09(1), 33208. https:\/\/doi.org\/10.3402\/gha.v9.33208","DOI":"10.3402\/gha.v9.33208"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Costa, L.J., Brill, I.K., Omel, J., Godby, K., Kumar, S.K., & Brown, E.E. (2017). Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States. Blood Advances,\u00a01(4), 282\u2013287.","DOI":"10.1182\/bloodadvances.2016002493"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Eggly, S., Hamel, L.M., Foster, T.S., Albrecht, T.L., Chapman, R., Harper, F.W.K., . . . Penner, L.A. (2017). Randomized trial of a question prompt list to increase patient active participation during interactions with black patients and their oncologists. Patient Education and Counseling, 100(5), 818\u2013826. https:\/\/doi.org\/10.1016\/j.pec.2016.12.026","DOI":"10.1016\/j.pec.2016.12.026"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Fiala, M.A., & Wildes, T.M. (2017). Racial disparities in treatment use for multiple myeloma. Cancer,\u00a0123(9), 1590\u20131596. https:\/\/doi.org\/10.1002\/cncr.30526","DOI":"10.1002\/cncr.30526"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Fillmore, N.R., Yellapragada, S.V., Ifeorah, C., Mehta, A., Cirstea, D., White, P.S., . . . Munshi, N.C. (2019). With equal access, African Americans have superior survival compared to white patients with multiple myeloma: A VA study. Blood, 133(24), 2615\u20132618. https:\/\/doi.org\/10.1182\/blood.2019000406","DOI":"10.1182\/blood.2019000406"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Freeman, A.T., Kuo, M., Zhou, L., Trogdon, J.G., Baggett, C.D., Tuchman, S.A., . . . Wood, W.A. (2019). Influence of treating facility, provider volume, and patient-sharing on survival of patients with multiple myeloma. Journal of the National Comprehensive Cancer Network,\u00a017(9), 1100\u20131108. https:\/\/doi.org\/10.6004\/jnccn.2019.7298","DOI":"10.6004\/jnccn.2019.7298"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Ghalehsari, N., Kancharla, P., Nimkar, N.S., Mazloom, A., Ashraf, F., Singh, A., & Goldfinger, M. (2019). An institutional retrospective study on recognizing the delay in multiple myeloma diagnosis. Blood,\u00a0134(Suppl. 1), 3430. https:\/\/doi.org\/10.1182\/blood-2019-127625","DOI":"10.1182\/blood-2019-127625"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Green, M.A., Michaels, M., Blakeney, N., Odulana, A.A., Isler, M.R., Richmond, A., . . . Corbie-Smith, G. (2015). Evaluating a community-partnered cancer clinical trials pilot intervention with African American communities.\u00a0Journal of Cancer Education,\u00a030(1), 158\u2013166.","DOI":"10.1007\/s13187-014-0764-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Hamel, L.M., Penner, L.A., Albrecht, T.L., Heath, E., Gwede, C.K., & Eggly, S. (2016). Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control, 23(4), 327\u2013337.","DOI":"10.1177\/107327481602300404"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Haynes-Maslow, L., Godley, P., Dimartino, L., White, B., Odom, J., Richmond, A., & Carpenter, W. (2014). African American women\u2019s perceptions of cancer clinical trials.\u00a0Cancer Medicine,\u00a03(5), 1430\u20131439. https:\/\/doi.org\/10.1002\/cam4.284","DOI":"10.1002\/cam4.284"},{"key":"22","unstructured":"International Myeloma Foundation. (2020). How is myeloma different in African Ameircans? https:\/\/www.myeloma.org\/diversity\/how-myeloma-different-african-americans"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Jayakrishnan, T., Bakalov, V., Wegner, R.E., & Sadashiv, S. (2019). Impact of socioeconomic factors on timeliness of first line chemotherapy and survival in patients with active multiple myeloma. Blood, 134(Suppl. 1), 4729. https:\/\/doi.org\/10.1182\/blood-2019-129147","DOI":"10.1182\/blood-2019-129147"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Kazandjian, D., Hill, E., Hultcrantz, M., Rustad, E.H., Yellapantula, V., Akhlaghi, T., . . . Landgren, O. (2019). Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients.\u00a0Blood Cancer Journal,\u00a09(2). https:\/\/doi.org\/10.1038\/s41408-019-0177-9","DOI":"10.1038\/s41408-019-0177-9"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Kumar, V., Ailawadhi, M., Abdulazeez, M.F., Biswas, S., Bodepudi, S.L., Bojanini, L., . . . Ailawadhi, S. (2019). A population-based analysis of predictors of survival and trends in outcomes of elderly patients with multiple myeloma (MM). Blood,\u00a0134(Suppl. 1), 4779. https:\/\/doi.org\/10.1182\/blood-2019-125156","DOI":"10.1182\/blood-2019-125156"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Meghani, S.H., Thompson, A.M.L., Chittams, J., Bruner, D.W., & Riegel, B. (2015). Adherence to analgesics for cancer pain: A comparative study of\u00a0African Americans and Whites using an electronic monitoring\u00a0device. Journal of Pain,\u00a016(9), 825\u2013835.","DOI":"10.1016\/j.jpain.2015.05.009"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Munjuluri, A., Fillmore, N., Cirstea, D., Yameen, H., Yellapragada, S.V., Chizoba, I., . . . Munshi, N.C. (2019). With equal access, African Americans with non-del17p multiple myeloma have superior overall survival, but del17p still carries poor prognosis across race: A VA study. Blood, 134(Suppl. 1), 4388.","DOI":"10.1182\/blood-2019-131247"},{"key":"28","unstructured":"National Cancer Institute. (2020). Surveillance, Epidemiology, and End Results Program: Cancer stat facts: Myeloma. https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Otado, J., Kwagyan, J., Edwards, D., Ukaegbu, A., Rockcliffe, F., & Osafo, N. (2015). Culturally competent strategies for recruitment and retention of African American populations into clinical trials. Clinical and Translational Science, 8(5), 460\u2013466. https:\/\/doi.org\/10.1111\/cts.12285","DOI":"10.1111\/cts.12285"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Pekmezi, D., Ainsworth, C., Desmond, R., Pisu, M., Williams, V., Wang, K., . . . Demark-Wahnefried, W. (2018). Physical activity maintenance following home-based, individually tailored print interventions for African American women. Health Promotion Practice, 21(2), 268\u2013276. https:\/\/doi.org\/10.1177\/1524839918798819","DOI":"10.1177\/1524839918798819"},{"key":"31","doi-asserted-by":"crossref","unstructured":"P\u00e9rez, M., Sefko, J.A., Ksiazek, D., Golla, B., Casey, C., Margenthaler, J.A., . . . Jeffe, D.B. (2013). A novel intervention using interactive technology and personal narratives to reduce cancer disparities: African American breast cancer survivor stories.\u00a0Journal of Cancer Survivorship,\u00a08(1), 21\u201330. https:\/\/doi.org\/10.1007\/s11764-013-0308-4","DOI":"10.1007\/s11764-013-0308-4"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Schoen, M.W., Carson, K.R., Luo, S., & Sanfilippo, K.M. (2019). Outcomes in multiple myeloma based on comorbidities and race. Blood, 134(Suppl. 1), 383.","DOI":"10.1182\/blood-2019-121807"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011). Cancer statistics, 2011.\u00a0CA: A Cancer Journal for Clinicians,\u00a061(4), 212\u2013236. https:\/\/doi.org\/10.3322\/caac.20121","DOI":"10.3322\/caac.20121"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Sobejano, E., Gonzalez de la Calle, V., Higuero, V., Escalante, F., Garc\u00eda-Sanz, R., Presa, D., . . . Mateos, M.V. (2019). Role of high-dose melphalan and autologous stem cell transplantation in multiple myeloma patients presenting with t(11;14). Blood, 134(Suppl. 1), 4580.","DOI":"10.1182\/blood-2019-129880"},{"key":"35","doi-asserted-by":"crossref","unstructured":"VanValkenburg, M.E., Pruitt, G.I., Brill, I.K., Costa, L., Ehtsham, M., Justement, I.T., . . . Brown, E.E. (2015). Family history of hematologic malignancies and risk of multiple myeloma: Differences by race and clinical features.\u00a0Cancer Causes and Control,\u00a027(1), 81\u201391.","DOI":"10.1007\/s10552-015-0685-2"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Vardell, V. (2019). Racial and socioeconomic disparities in the utilization of autologous stem cell transplant for treatment of multiple myeloma in the era of novel agents. Blood, 134(Suppl. 1), 423.","DOI":"10.1182\/blood-2019-130859"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Waxman, A.J., Mink, P.J., Devesa, S.S., Anderson, W.F., Weiss, B.M., Kristinsson, S.Y., . . . Landgren, O. (2010). Racial disparities in incidence and outcome in multiple myeloma: A population-based study. Blood, 116(25), 5501\u20135506.","DOI":"10.1182\/blood-2010-07-298760"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/cjon.ons.org\/cjon\/24\/4\/african-american-patients-multiple-myeloma-optimizing-care-decrease-racial-disparities","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:50:15Z","timestamp":1763754615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/24\/4\/african-american-patients-multiple-myeloma-optimizing-care-decrease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.1188\/20.cjon.439-443","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2020,8,1]]}}}